Epstein-Barr virus-associated hepatic smooth muscle neoplasm in a cardiac transplant recipient

Andrew M. Davidoff, Andre Hebra, Bernard J. Clark, John E. Tomaszewski, Kathleen T. Montone, Eduardo Ruchelli, Henry T. Lau

Research output: Contribution to journalArticle

Abstract

Host immunosuppression is increasingly recognized as a significant risk factor for the development of a primary neoplasm. Chronic immunosuppressive therapy, as used in organ transplantation, may perturb the immunosurveillance ability of the host, making the patient more susceptible to virus-associated malignancies. We have taken care of a child who received an orthotopic heart transplant and who then developed both a generalized lymphoproliferative disorder and a leiomyoma of the liver a year later. Epstein-Barr virus DNA was detected in a lymph node initially and the hepatic tumor cells subsequently. The former responded to a reduction in the immunosuppressive medications and the latter responded to surgical resection. This is the first report of a hepatic smooth cell neoplasm occurring following cardiac transplant and the development of two sequential Epstein-Barr virus- associated disorders in an immunosuppressed patient.

Original languageEnglish (US)
Pages (from-to)515-517
Number of pages3
JournalTransplantation
Volume61
Issue number3
DOIs
StatePublished - Feb 15 1996
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Fingerprint Dive into the research topics of 'Epstein-Barr virus-associated hepatic smooth muscle neoplasm in a cardiac transplant recipient'. Together they form a unique fingerprint.

  • Cite this

    Davidoff, A. M., Hebra, A., Clark, B. J., Tomaszewski, J. E., Montone, K. T., Ruchelli, E., & Lau, H. T. (1996). Epstein-Barr virus-associated hepatic smooth muscle neoplasm in a cardiac transplant recipient. Transplantation, 61(3), 515-517. https://doi.org/10.1097/00007890-199602150-00036